Zinda Michael 4
4 · Repare Therapeutics Inc. · Filed Mar 6, 2025
Insider Transaction Report
Form 4
Zinda Michael
EVP, CHIEF SCIENTIFIC OFFICER
Transactions
- Award
Common Shares
2025-03-04+14,000→ 85,908 total - Award
Employee Stock Option (right to buy)
2025-03-04+75,000→ 75,000 totalExercise: $1.17Exp: 2035-03-03→ Common Shares (75,000 underlying) - Award
Employee Stock Option (right to buy)
2025-03-04+85,000→ 85,000 totalExercise: $1.17Exp: 2035-03-03→ Common Shares (85,000 underlying)
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award. Thirty-three and one third percent (33 1/3%) of the RSUs shall vest on each of March 4, 2026, March 4, 2027 and March 4, 2028, subject to Reporting Person continuing to provide service through each such date.
- [F2]The option will vest in in full on March 4, 2026, subject to Reporting Person continuing to provide service through such date.
- [F3]Twenty-five percent (25%) of the shares subject to the option shall vest on March 4, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.